Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination

Pascal Irrgang, Juliane Gerling, Katharina Kocher, +20

Science Immunology

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization

Dennis Lapuente, Jana Fuchs, Jonas Willar, +20

Nature Communications

Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2

Dennis Lapuente, Clara Maier, Pascal Irrgang, +13

European Journal of Clinical Microbiology & Infectious Diseases

XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors

Lukas Heger, Lukas Hatscher, Chunguang Liang, +17

Proceedings of the National Academy of Sciences

Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)

Jürgen Held, Jan Esse, Koray Taşçılar, +7

Vaccines

Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2

Emanuel Vogel, Katharina Kocher, Alina Priller, +27

EBioMedicine

Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity

Clara Maier, Jana Fuchs, Pascal Irrgang, +4

Frontiers in Immunology

Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections

Timo Huber, Philipp Steininger, Pascal Irrgang, +9

European Journal of Clinical Microbiology & Infectious Diseases

Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases

Friederike Oltmanns, Ana Vieira Antão, Pascal Irrgang, +13

Journal for ImmunoTherapy of Cancer